Sanofi presses on with threat to oust Medivation's board

(Reuters) – France’s Sanofi SA was moving ahead on Friday with preparations to replace Medivation Inc’s board of directors after the U.S. cancer drug maker refused to engage with it in sale talks based on a $9.3 billion acquisition offer.


Source: ReutersBusinessNews

Sanofi presses on with threat to oust Medivation's board